诺华的下一代临床平台助力人工智能药物研发.pdf

1、 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.S P S 3 1 4Novartiss Next-Gen Data Platform Enables AI Drug DevelopmentAnna KlebusGlobal Head Data,Digital and IT,Drug Development,Novartis Pharma AGKaustubh PatilSe

2、nior Manager,Healthcare&Life Sciences,AWS Professional ServicesApoorva JoshiSenior Delivery Consultant,Project Technical Lead,AWS Professional Services 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.Agenda1.Novartis Data&AI Modernization Story2.Novartis NextGen Data Platform 3.Ho

3、w to Get Started&Modernize your Data&AI Journey3 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.1.Novartis Data&AI Modernization Story 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.10-15 years

4、to develop a new medicineSource:IPFMA_REPORT-2025Average cost to develop a new medicine$2.6B26%The average time from clinical trial start to patient enrolment close increased by 26%from 2019 to 2023 For every 100 phase I trial starts only 10 has probability of market entryChances of success for comp

5、ounds inpreclinical research12 months fasterOperations(Clinical)Improved processes and ways of working,translating to 1-2 years acceleration for select drug candidatesAI Enabled(Composite)Leverage AI and technology to accelerate drug development cycle time by 6 months77 2025,Amazon Web Services,Inc.

6、or its affiliates.All rights reserved.A new and AI based transformation is emergingWhile drug development is complex,lengthy&resource-intensive there is opportunity for AI to solve for these uncertainties and help shorten trial timelines by 6 monthsDescribe and predict complex behaviours of patient